Save
Email
Print
Share
RSSBrowse News Stories
11 to 20 of 4,154 stories
view headlines only
-
Scientists ID Compounds That Target Amyloid Fibrils in Alzheimer's, Other Brain Diseases
July 26, 2013 — Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's ... > full story -
Genetic Biomarker Detects Lewy Body Dementia
July 26, 2013 — Scientists have discovered the first genetic biomarker to detect Lewy body dementia (LBD), a disease that can be confused with Alzheimer's. This biomarker is found in 20% of cases and differentiates ... > full story -
Certain Blood Pressure Drugs Slow Dementia Deterioration
July 25, 2013 — A class of drug, called ACE inhibitors, which are used to lower blood pressure, slow the rate of cognitive decline typical of dementia, suggests new ... > full story -
Rapamycin: Limited Anti-Aging Effects
July 25, 2013 — The drug rapamycin is known to increase lifespan in mice. Whether rapamycin slows down aging, however, remains unclear. Scientists have now found that rapamycin extends lifespan -- but its impact on ... > full story -
Over 90 Percent of Dementia Cases in China Are Undetected, Study Finds
July 25, 2013 — An international team of researchers has found that over 90 percent of dementia cases in China go undetected, with a high level of undiagnosed dementia in rural ... > full story -
Key Molecular Pathways Leading to Alzheimer's Identified
July 24, 2013 — Key molecular pathways that lead to late-onset Alzheimer's disease have been identified by neuroscientists. The findings present a new approach to Alzheimer’s research and highlight several new ... > full story -
Sleep Deprivation Linked to Aging Skin, Study Suggests
July 23, 2013 — In a first-of-its-kind clinical trial, physician-scientists found that sleep quality impacts skin function and aging. The study, commissioned by Estée Lauder, demonstrated that poor sleepers ... > full story -
Chronic Illness
Multiple Sclerosis Research
Multiple Sclerosis
Diseases and Conditions
Marijuana
Controlled Substances
Cannabis Constituent Has No Effect on Multiple Sclerosis Progression, Study Shows
July 23, 2013 — The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple ... > full story -
Early Detection and Treatment of Alzheimer's Disease Prevents Psychological and Behavioural Symptoms
July 18, 2013 — Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioral symptoms if the diagnosis is made and treatment begun at a ... > full story -
Updated Results from Phase 3 Trial of IVIG for Alzheimer's Disease
July 16, 2013 — Neurologists have reported new findings from the Phase 3 clinical trial of IVIG (intravenous immunoglobulin) in mild to moderate Alzheimer's disease. While the primary study outcomes were negative, ... > full story
Search ScienceDaily
Number of stories in archives: 140,690
more 
